Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials.

1 A and graphical abstract), which did not reach statistical significance, but a 19% reduction (RR 0.81; 95% CI: 0.69 – 0.95, p = 0.02) when the analysis was restricted to 14 days from randomisation (5/11 trials, 1329 patients) ( Fig. 1 B).

also in 111,027 other papers